Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner June 15, 2021 DPP4 Inhibitors vs GLP-1 Agonists There are no guidelines that support the combined use of a GLP1 agonist and a DPP4 inhibitor
In both cases, the body is returning to equilibrium , not wasting away
Recently, it has been recognised that gastric emptying, even when normal, is a major, and hitherto generally underappreciated, determinant of the magnitude of the postprandial rise in blood glucose, which, in many individuals with diabetes, predominates over fasting blood glucose in determining average glycaemic control as assessed by HbA 1c
PMC 4020673
Whilst GLP-1 medications do not directly target reproductive hormones, the substantial metabolic and weight changes they induce can have indirect effects on menstrual function , which warrants careful consideration for women of reproductive age
